(2018) Efficacy and tolerability of a new thermostable formulation of latanoprost in nanoparticles

Año:

2018

Molécula / Formulación / Marca:

Latanoprost 0,005% emulsión (Louten)

Diseño:

Prospectivo switch

Revista / Congreso:

Association for Research in Vision & Ophthalmology (ARVO) 2018

Cita bibliográfica / Locación:

Honolulu, Hawai

Estudio clínico

Autores:

Rodríguez Lourdes

Casiraghi Javier Grigera Daniel Peyret Alejo Passerini Silvia

Palabras claves:

BAK-free, glaucoma, latanoprost, nanoemulsion, superficieocular, toxicidad

Estudios relacionados

Triple-fixed Combination of Dorzolamide/Timolol/Brimonidine: Efficacy Study in Bolivian Population

– Por Justiniano Manuel José

Efficacy and safety of an innovative formulation of benzalkonium chloride-free latanoprost for the treatment of open-angle glaucoma

– Por Zanutigh Virginia

A Comparative Study of Difluprednate 0.05% Nanoemulsion Vs Prednisolone Acetate 1% + Phenylephrine 0.12% Suspension on Postoperative Inflammation Treatment Following Cataract Surgery

– Por Valvecchia Gerardo

(2019) Efficacy and tolerability of a new thermostable formulation of latanoprost in nanoparticles

– Por Passerini Silvia

Efficacy and Toxicity Evaluation of Bepotastine Besilate 1.5% Preservative-Free Eye Drops Vs Olopatadine Hydrochloride 0.2% Bak-Preserved Eye Drops in Patients with Allergic Conjunctivitis

– Por Marini Cecilia

Difluprednate 0.05% twice a day vs prednisolone acetate 1% 4 times a day forcataract postsurgical inflammation treatment:noninferiority trial

– Por Valvecchia Gerardo